Morgan Stanley Discount Zert MRNA.../ DE000ME5M856 /

2024-05-24 9:50:23 PM	Chg.-0.27	Bid10:00:32 PM	Ask10:00:32 PM	Underlying	Strike price	Expiration date	Option type
85.11EUR	-0.32%	- Bid Size: -	- Ask Size: -	Moderna Inc	- USD	2024-06-28	Call

GlobeNewswire 05-22 CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference

GlobeNewswire 05-22 Oruka Therapeutics Expands Leadership Team with Appointment of Industry Veterans Drs. Joseph Senn an...

TeleTrader 05-20 Dow slumps 195 points at closing bell after corporate news

GlobeNewswire 05-16 CytomX Therapeutics Announces New Employment Inducement Grants

TeleTrader 05-13 Wall Street closes mixed ahead of key inflation data

GlobeNewswire 05-12 TrialWire Patient Recruitment Platform that Reboots Stalled Clinical Trials announced as Multi-Award...

GlobeNewswire 05-08 CytomX Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update

GlobeNewswire 05-08 Mitigating Muscle Loss Becoming More Vital, Global Cancer Cachexia Market Projected to Reach $3.3 Bi...

TeleTrader 05-02 US surges at close as traders weigh Fed remarks

TeleTrader 05-02 Moderna surges 9% as Q1 revenue beat expectations

GlobeNewswire 05-02 Arbutus Reports First Quarter 2024 Financial Results and Provides Corporate Update

TeleTrader 05-02 Moderna sees $167M in Q1 revenue, beats forecasts

TeleTrader 05-02 US higher premarket after Fed's decision

GlobeNewswire 05-01 Metagenomi to regain full development rights to its wholly-owned base editing and RIGS systems

GlobeNewswire 05-01 CytomX Therapeutics to Report First Quarter 2024 Results and Provide an Initial CX-904 Phase 1a Clin...

TeleTrader 04-24 Moderna, OpenAI partner on mRNA medicine advancement

TeleTrader 04-09 US markets close mostly higher ahead of inflation report

GlobeNewswire 04-04 Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Aga...

TeleTrader 03-28 US closes mixed amid data

TeleTrader 03-26 Wall Street closes lower after economic data

GlobeNewswire 03-21 Immatics Announces Full Year 2023 Financial Results and Corporate Update

GlobeNewswire 03-11 CytomX Therapeutics Reports 2023 Financial Results and Provides Business Update

GlobeNewswire 03-04 CytomX Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024

GlobeNewswire 02-29 Arbutus Reports Fourth Quarter and Year End 2023 Financial Results and Provides Corporate Update

GlobeNewswire 02-27 CytomX Therapeutics to Present at Upcoming March Investor Conferences